Fatty15 Secures Four Industry Awards as C15:0 Gains Market Traction
San Diego-based Seraphina Therapeutics has claimed four major industry honors in 2026, marking a significant milestone for its signature supplement, fatty15. The accolades underscore the brand's rapid ascent in the health and wellness sector, driven by its focus on the first essential fatty acid discovery in nearly a century.
The company’s flagship product, fatty15, earned the Mindful Award for Wellness Company of the Year and the Beauty Shortlist 15th Anniversary Wellbeing award. Additionally, Global Health & Pharma (GHP) recognized the brand as the top essential fatty acid supplement while granting it an excellence award for customer satisfaction. These honors arrive amid a surge in the product's popularity, supported by a 95% monthly retention rate among its 100,000 active subscribers.
Dr. Eric Venn-Watson, co-founder and co-CEO of Seraphina Therapeutics, attributed the success to a decade of rigorous research into C15:0, or pentadecanoic acid. The nutrient, which is backed by over 150 peer-reviewed studies, is marketed as a foundational supplement to support cellular health, metabolic function, and immune balance. Beyond industry recognition, the product recently achieved a 9.88 trust score from SuppCo Certified, placing it in the top 1% of over 160,000 supplements evaluated. As the company continues to scale, it maintains that its core mission remains the integration of scientific discovery into accessible, daily nutritional routines.
Comments (0)
No comments yet. Be the first!